Zdrowie i gospodarka · 17/11/2017
FDA Announces Public Comment Period for Proposed Collection of Information on Meetings with Office of Orphan Products Development
The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to meetings with the Office of Orphan Products Development, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →